Targeted therapy with galantamine in a pediatric patient with 15q13.3 deletion syndrome

Am J Med Genet A. 2021 Dec;185(12):3897-3899. doi: 10.1002/ajmg.a.62425. Epub 2021 Jul 17.
No abstract available

MeSH terms

  • Child, Preschool
  • Chromosome Deletion
  • Chromosome Disorders / drug therapy*
  • Chromosome Disorders / genetics
  • Chromosomes, Human, Pair 15 / genetics
  • Female
  • Galantamine / administration & dosage*
  • Humans
  • Intellectual Disability / drug therapy*
  • Intellectual Disability / genetics
  • Molecular Targeted Therapy*
  • Pediatrics
  • Seizures / drug therapy*
  • Seizures / genetics
  • alpha7 Nicotinic Acetylcholine Receptor / antagonists & inhibitors
  • alpha7 Nicotinic Acetylcholine Receptor / genetics*

Substances

  • Chrna7 protein, human
  • alpha7 Nicotinic Acetylcholine Receptor
  • Galantamine

Supplementary concepts

  • Chromosome 15q13.3 Microdeletion Syndrome